Steven Wohnoutka

Steven Wohnoutka has over 20 years of work experience in the pharmaceutical industry. Steven is currently employed at Taiho Oncology, Inc. as an Associate Regional Business Director since April 2021. Prior to this role, they worked at Taiho Oncology, Inc. as an Oncology Account Manager from August 2015 to April 2021. Before joining Taiho Oncology, Inc., Steven worked at Astellas Pharma as a Sr. Executive Sales Representative I, Oncology from April 2013 to August 2015, where they successfully launched Xtandi for metastatic prostate cancer. Steven also worked at Dendreon as an Immunotherapy Sales Specialist from January 2011 to April 2013. Prior to that, they worked at Cephalon Oncology as an Oncology Sales Specialist from 2008 to 2011. Steven started their career at MedImmune Oncology as a Sr. Oncology Sales Specialist from 2001 to October 2007. Before joining MedImmune Oncology, they worked at UroCor, Inc. as a Regional Sales Manager from 1997 to 2001.

Steven Wohnoutka earned a Bachelor of Science degree in Radiological Science from Midwestern State University, which they attended from 1988 to 1992. Steven later pursued studies in Radiation Biology/Radiobiology at the same institution, although specific dates are not provided.